Interventions for valvular disease and heart failure

Impact of right ventricular-pulmonary arterial coupling on clinical outcomes of tricuspid regurgitation

EuroIntervention 2022;18:852-861. DOI: 10.4244/EIJ-D-22-00045

Atsushi Sugiura
Atsushi Sugiura1, MD, PhD; Refik Kavsur1, MD; Maximilian Spieker2, MD; Christos Iliadis3, MD; Victor Mauri3, MD; Tetsu Tanaka1, MD; Tadahiro Goto4, MD, MPH, PhD; Marcel Weber1, MD; Malte Kelm2, MD; Stephan Baldus3, MD; Georg Nickenig1, MD; Ralf Westenfeld2, MD; Roman Pfister3, MD; Marc Ulrich Becher1, MD
1. Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Bonn, Germany; 2. Heart Center, Department of Cardiology, University Hospital Düsseldorf, Düsseldorf, Germany; 3. Heart Center, Department of Cardiology, University Hospital Cologne, Cologne, Germany; 4. Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Tokyo, Japan

Background: In terms of pathophysiology, tricuspid regurgitation (TR) and right ventricular (RV) function are linked to each other.

Aims: This study sought to evaluate RV-pulmonary artery (PA) coupling and its impact on clinical outcomes of TR in patients undergoing mitral transcatheter edge-to-edge repair (TEER).

Methods: We calculated RV-PA coupling ratios in patients undergoing mitral TEER from August 2010 to March 2019 by dividing the tricuspid annular plane systolic excursion (TAPSE) by the echocardiographic estimated PA systolic pressure (PASP). TR was graded as none/trace, mild, moderate, or severe. The primary outcome was all-cause mortality or rehospitalisation within 12 months.

Results: Among 744 patients analysed, severe TR was documented in 22.3% of patients and the mean TAPSE/PASP was 0.43±0.25. Technical success of TEER was achieved in 97.2% of participants. Severe TR vs TR ≤moderate (adjusted HR 1.92, 95% CI: 1.39-2.66) and TAPSE/PASP (adjusted HR 0.45, 95% CI: 0.22-0.93) were associated with the outcome. Patients were divided according to the TAPSE/PASP tertile. Compared to patients with TR ≤moderate, patients with severe TR had a higher event rate (TAPSE/PASP <0.30: 32.9% vs 45.1%; 0.30≤ TAPSE/PASP <0.44: 27.8% vs 41.8%; TAPSE/PASP ≥0.44: 16.0% vs 40.4%), whereas the prognostic significance of TR was attenuated in patients with reduced TAPSE/PASP (i.e., RV-PA uncoupling; interaction term p=0.03). The trends were consistent in the multivariable regression models, spline curves, and sensitivity analysis using post-interventional parameters.

Conclusions: RV-PA coupling affects the outcome correlation of TR in patients undergoing mitral TEER. The prognostic impact of TR is attenuated in patients with RV-PA uncoupling.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

mitral regurgitationmitral valve repairrisk stratificationtricuspid disease
Read next article
First-in-human implantation of the Topaz transcatheter tricuspid valve replacement system

Latest news